Free Trial

FIL Ltd Sells 82,104 Shares of Afya Limited (NASDAQ:AFYA)

Afya logo with Consumer Discretionary background
Remove Ads

FIL Ltd cut its stake in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 49.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 84,514 shares of the company's stock after selling 82,104 shares during the period. FIL Ltd owned approximately 0.09% of Afya worth $1,342,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in AFYA. Public Employees Retirement System of Ohio acquired a new position in shares of Afya during the 3rd quarter valued at $34,000. Blue Trust Inc. raised its stake in Afya by 296.9% during the fourth quarter. Blue Trust Inc. now owns 2,072 shares of the company's stock worth $35,000 after acquiring an additional 1,550 shares during the period. JPMorgan Chase & Co. boosted its position in Afya by 2,115.9% during the 4th quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock valued at $106,000 after purchasing an additional 6,369 shares during the period. Van ECK Associates Corp increased its stake in shares of Afya by 41.9% in the fourth quarter. Van ECK Associates Corp now owns 9,677 shares of the company's stock valued at $154,000 after purchasing an additional 2,856 shares during the period. Finally, Lifestyle Asset Management Inc. boosted its position in Afya by 5.5% during the 4th quarter. Lifestyle Asset Management Inc. now owns 17,682 shares of the company's stock worth $281,000 after acquiring an additional 929 shares during the period. Institutional investors and hedge funds own 88.02% of the company's stock.

Afya Stock Performance

Shares of AFYA stock traded up $0.05 on Wednesday, hitting $17.98. The company's stock had a trading volume of 67,204 shares, compared to its average volume of 121,484. The company has a market capitalization of $1.69 billion, a PE ratio of 14.50, a PEG ratio of 0.29 and a beta of 0.66. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. The stock's 50 day moving average is $17.35 and its 200-day moving average is $16.65. Afya Limited has a fifty-two week low of $14.52 and a fifty-two week high of $20.06.

Remove Ads

Afya Announces Dividend

The company also recently disclosed a -- dividend, which was paid on Friday, April 4th. Stockholders of record on Wednesday, March 26th were paid a $0.232 dividend. The ex-dividend date was Wednesday, March 26th. Afya's dividend payout ratio is currently 17.69%.

Analysts Set New Price Targets

AFYA has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. decreased their price target on Afya from $25.00 to $20.50 and set a "neutral" rating for the company in a research report on Friday, January 17th. Morgan Stanley downgraded shares of Afya from an "equal weight" rating to an "underweight" rating and decreased their price objective for the stock from $19.00 to $17.00 in a report on Tuesday, March 11th. Finally, Citigroup reiterated a "sell" rating and issued a $15.00 target price (down previously from $18.00) on shares of Afya in a research note on Friday, January 31st. Three analysts have rated the stock with a sell rating and two have given a hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Reduce" and an average price target of $17.60.

Check Out Our Latest Report on AFYA

About Afya

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

See Also

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads